Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

This study has been terminated.
Sponsor:
Information provided by:
Health Innovations, Frontier Research Institute
ClinicalTrials.gov Identifier:
NCT01250743
First received: November 29, 2010
Last updated: February 17, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)